These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 25865237)

  • 41. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor.
    Noren NK; Yang NY; Silldorff M; Mutyala R; Pasquale EB
    Biochem J; 2009 Aug; 422(3):433-42. PubMed ID: 19552627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells.
    Foubert P; Silvestre JS; Souttou B; Barateau V; Martin C; Ebrahimian TG; Leré-Déan C; Contreres JO; Sulpice E; Levy BI; Plouët J; Tobelem G; Le Ricousse-Roussanne S
    J Clin Invest; 2007 Jun; 117(6):1527-37. PubMed ID: 17510705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EphB4 signaling is capable of mediating ephrinB2-induced inhibition of cell migration.
    Sturz A; Bader B; Thierauch KH; Glienke J
    Biochem Biophys Res Commun; 2004 Jan; 313(1):80-8. PubMed ID: 14672701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of bidirectional EphB4-EphrinB2 signaling on bone remodeling].
    Fan WB; Zhao JN; Bao NR
    Zhongguo Gu Shang; 2013 Aug; 26(8):705-8. PubMed ID: 24266083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma.
    Randolph ME; Cleary MM; Bajwa Z; Svalina MN; Young MC; Mansoor A; Kaur P; Bult CJ; Goros MW; Michalek JE; Xiang S; Keck J; Krasnoperov V; Gill P; Keller C
    PLoS One; 2017; 12(8):e0183161. PubMed ID: 28817624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade.
    Scehnet JS; Ley EJ; Krasnoperov V; Liu R; Manchanda PK; Sjoberg E; Kostecke AP; Gupta S; Kumar SR; Gill PS
    Blood; 2009 Jan; 113(1):254-63. PubMed ID: 18836096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis.
    Kim YH; Hu H; Guevara-Gallardo S; Lam MT; Fong SY; Wang RA
    Development; 2008 Nov; 135(22):3755-64. PubMed ID: 18952909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The protective role of Ephrin-B2/EphB4 signaling in osteogenic differentiation under inflammatory environment.
    Qu F; Song Y; Wu Y; Huang Y; Zhong Q; Zhang Y; Fan Z; Xu C
    Exp Cell Res; 2021 Mar; 400(2):112505. PubMed ID: 33516666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EphrinB2-EphB4-RASA1 Signaling in Human Cerebrovascular Development and Disease.
    Zeng X; Hunt A; Jin SC; Duran D; Gaillard J; Kahle KT
    Trends Mol Med; 2019 Apr; 25(4):265-286. PubMed ID: 30819650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Br J Cancer; 2008 Feb; 98(4):845-51. PubMed ID: 18231102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human leukocytes express ephrinB2 which activates microvascular endothelial cells.
    Zamora DO; Babra B; Pan Y; Planck SR; Rosenbaum JT
    Cell Immunol; 2006 Aug; 242(2):99-109. PubMed ID: 17123494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth.
    Abéngozar MA; de Frutos S; Ferreiro S; Soriano J; Perez-Martinez M; Olmeda D; Marenchino M; Cañamero M; Ortega S; Megias D; Rodriguez A; Martínez-Torrecuadrada JL
    Blood; 2012 May; 119(19):4565-76. PubMed ID: 22446484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positively charged polymers modulate the fate of human mesenchymal stromal cells via ephrinB2/EphB4 signaling.
    De Luca I; Di Salle A; Alessio N; Margarucci S; Simeone M; Galderisi U; Calarco A; Peluso G
    Stem Cell Res; 2016 Sep; 17(2):248-255. PubMed ID: 27591481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological Significance of EphB4 Expression in Cancer.
    Ullah A; Razzaq A; Zhou C; Ullah N; Shehzadi S; Aziz T; Alfaifi MY; Elbehairi SEI; Iqbal H
    Curr Protein Pept Sci; 2024; 25(3):244-255. PubMed ID: 37909437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
    Du E; Li X; He S; Li X; He S
    Mol Biol Rep; 2020 Jun; 47(6):4681-4690. PubMed ID: 32488576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EphrinB2 and EphB4 expression in pterygia: new insights and preliminary results.
    Xue C; Huang Z; Wang J; Dong Y; Zhou X
    Can J Ophthalmol; 2009 Apr; 44(2):185-8. PubMed ID: 19491953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intermittent parathyroid hormone promotes cementogenesis via ephrinB2-EPHB4 forward signaling.
    Li T; Wang H; Lv C; Huang L; Zhang C; Zhou C; Zou S; Duan P
    J Cell Physiol; 2021 Mar; 236(3):2070-2086. PubMed ID: 32740946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
    Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
    J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand.
    Yang NY; Lopez-Bergami P; Goydos JS; Yip D; Walker AM; Pasquale EB; Ethell IM
    Pigment Cell Melanoma Res; 2010 Oct; 23(5):684-7. PubMed ID: 20649938
    [No Abstract]   [Full Text] [Related]  

  • 60. Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.
    Hamada K; Oike Y; Ito Y; Maekawa H; Miyata K; Shimomura T; Suda T
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):190-7. PubMed ID: 12588758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.